DE2655500A1 - Glucosaminderivate und ein verfahren zu deren herstellung - Google Patents

Glucosaminderivate und ein verfahren zu deren herstellung

Info

Publication number
DE2655500A1
DE2655500A1 DE19762655500 DE2655500A DE2655500A1 DE 2655500 A1 DE2655500 A1 DE 2655500A1 DE 19762655500 DE19762655500 DE 19762655500 DE 2655500 A DE2655500 A DE 2655500A DE 2655500 A1 DE2655500 A1 DE 2655500A1
Authority
DE
Germany
Prior art keywords
carbamoyl
hydrogen
deoxy
methyl
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19762655500
Other languages
German (de)
English (en)
Other versions
DE2655500C2 (no
Inventor
Gerhard Dr Baschang
Albert Dr Hartmann
Alex Sele
Jaroslav Dr Stanek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE2655500A1 publication Critical patent/DE2655500A1/de
Application granted granted Critical
Publication of DE2655500C2 publication Critical patent/DE2655500C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19762655500 1975-12-10 1976-12-08 Glucosaminderivate und ein verfahren zu deren herstellung Granted DE2655500A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (2)

Publication Number Publication Date
DE2655500A1 true DE2655500A1 (de) 1977-06-23
DE2655500C2 DE2655500C2 (no) 1988-12-22

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762655500 Granted DE2655500A1 (de) 1975-12-10 1976-12-08 Glucosaminderivate und ein verfahren zu deren herstellung

Country Status (30)

Country Link
JP (1) JPS5273820A (no)
AR (2) AR224091A1 (no)
AT (1) AT365607B (no)
AU (1) AU508764B2 (no)
BE (1) BE849214A (no)
CA (1) CA1262400A (no)
CH (2) CH613709A5 (no)
CS (4) CS205026B2 (no)
DD (1) DD129781A5 (no)
DE (1) DE2655500A1 (no)
DK (1) DK154654C (no)
ES (2) ES454118A1 (no)
FI (1) FI64164C (no)
FR (1) FR2361902A1 (no)
GB (1) GB1570625A (no)
GR (1) GR61647B (no)
HK (1) HK32883A (no)
HU (1) HU177970B (no)
IE (1) IE44190B1 (no)
IL (1) IL51076A (no)
MY (1) MY8400123A (no)
NL (1) NL7613666A (no)
NO (1) NO144850C (no)
NZ (1) NZ182837A (no)
PL (4) PL110787B1 (no)
PT (1) PT65946B (no)
SE (1) SE445923B (no)
SG (1) SG11083G (no)
SU (3) SU660589A3 (no)
ZA (1) ZA767333B (no)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718010A1 (de) * 1976-04-26 1977-11-10 Syntex Inc Neue immunologische adjuvansverbindungen und verfahren zur herstellung derselben
US4235771A (en) * 1973-10-23 1980-11-25 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
EP0026746A1 (de) * 1979-10-02 1981-04-08 Ciba-Geigy Ag Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
EP0056992A1 (de) * 1981-01-23 1982-08-04 Ciba-Geigy Ag Phosphorylverbindungen, pharmazeutische Präparate enthaltend solche Verbindungen, sowie ihre Verwendung
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4401659A (en) * 1979-01-12 1983-08-30 Agence National De Valorisation De La Recherche (Anvar) Muramyl-peptides fixed to peptide-polymers and pharmaceutical compositions containing them
US4427659A (en) 1979-02-20 1984-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Muramyl peptide substituted on a peptide nitrogen and medicaments containing the same
US4430265A (en) 1977-12-02 1984-02-07 Takeda Chemical Industries, Ltd. Glucosamine derivatives
US4446128A (en) * 1978-02-24 1984-05-01 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US5264431A (en) * 1991-11-07 1993-11-23 Ciba-Geigy Corp. Polycyclic conjugates

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
FI803077A (fi) 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
WO2006118327A1 (ja) * 2005-04-27 2006-11-09 Oxygenix Co Ltd カチオン性アミノ酸型脂質
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
MX2020002010A (es) 2017-08-21 2020-07-13 Celgene Corp Procesos para la preparacion de 4,5-diamino-5-oxopentanoato de (s)-terc-butilo.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2450355A1 (de) * 1973-10-23 1975-05-28 Anvar Aus n-acyl-muraminsaeurederivaten gebildete adjuvanzien und diese enthaltende impfstoffe

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2450355A1 (de) * 1973-10-23 1975-05-28 Anvar Aus n-acyl-muraminsaeurederivaten gebildete adjuvanzien und diese enthaltende impfstoffe

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Biochem. Biophys. Res. Commun. 59, 1974, S.1317-1325 *
C.A., 83, 1975, 161981 *
ibido, 66, 1975, S.1316-1322 *
J. Med. Chem., 9, 1966, S.971-975 *
Z. Immun.-Forsch., 149, 1975, S.341-348 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235771A (en) * 1973-10-23 1980-11-25 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4323559A (en) * 1973-10-23 1982-04-06 Agencie Nationale De Valorisation De La Recherche (Anvar) Compounds derived from N-acetyl-nor-muramyl-L-alanyl-D-isoglutamic acid and other compounds and biologically active compositions containing such compounds
US4327085A (en) * 1973-10-23 1982-04-27 Agence National De Valorisation De La Recherache (Anvar) Biologically active compositions and methods of use
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
DE2718010A1 (de) * 1976-04-26 1977-11-10 Syntex Inc Neue immunologische adjuvansverbindungen und verfahren zur herstellung derselben
US4430265A (en) 1977-12-02 1984-02-07 Takeda Chemical Industries, Ltd. Glucosamine derivatives
US4446128A (en) * 1978-02-24 1984-05-01 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4401659A (en) * 1979-01-12 1983-08-30 Agence National De Valorisation De La Recherche (Anvar) Muramyl-peptides fixed to peptide-polymers and pharmaceutical compositions containing them
US4427659A (en) 1979-02-20 1984-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Muramyl peptide substituted on a peptide nitrogen and medicaments containing the same
EP0026746A1 (de) * 1979-10-02 1981-04-08 Ciba-Geigy Ag Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
EP0056992A1 (de) * 1981-01-23 1982-08-04 Ciba-Geigy Ag Phosphorylverbindungen, pharmazeutische Präparate enthaltend solche Verbindungen, sowie ihre Verwendung
US5264431A (en) * 1991-11-07 1993-11-23 Ciba-Geigy Corp. Polycyclic conjugates

Also Published As

Publication number Publication date
AR220686A1 (es) 1980-11-28
FI64164B (fi) 1983-06-30
ZA767333B (en) 1977-11-30
DK154654C (da) 1989-05-08
CH613709A5 (en) 1979-10-15
SU747430A3 (ru) 1980-07-23
FR2361902B1 (no) 1980-11-07
DK552476A (da) 1977-06-11
IE44190B1 (en) 1981-09-09
CS205028B2 (en) 1981-04-30
SG11083G (en) 1983-09-16
SE7613851L (sv) 1977-06-11
DD129781A5 (de) 1978-02-08
PL110353B1 (en) 1980-07-31
PT65946B (en) 1978-06-14
FR2361902A1 (fr) 1978-03-17
PL194291A1 (pl) 1978-10-23
MY8400123A (en) 1984-12-31
AT365607B (de) 1982-02-10
NL7613666A (nl) 1977-06-14
DE2655500C2 (no) 1988-12-22
FI763541A (no) 1977-06-11
ATA909276A (de) 1981-06-15
PL110787B1 (en) 1980-07-31
ES454118A1 (es) 1978-03-01
NO144850C (no) 1981-11-25
PL110794B1 (en) 1980-07-31
HK32883A (en) 1983-09-02
NZ182837A (en) 1978-07-28
CS205025B2 (en) 1981-04-30
CS205027B2 (en) 1981-04-30
CS205026B2 (en) 1981-04-30
AR224091A1 (es) 1981-10-30
DK154654B (da) 1988-12-05
IL51076A (en) 1980-09-16
FI64164C (fi) 1983-10-10
IE44190L (en) 1977-06-10
CA1262400A (en) 1989-10-17
BE849214A (fr) 1977-06-09
JPS638118B2 (no) 1988-02-19
PL112672B1 (en) 1980-10-31
IL51076A0 (en) 1977-02-28
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
AU508764B2 (en) 1980-04-03
JPS5273820A (en) 1977-06-21
SU660589A3 (ru) 1979-04-30
HU177970B (en) 1982-02-28
ES465514A1 (es) 1978-09-16
SE445923B (sv) 1986-07-28
AU2042276A (en) 1978-06-15
PT65946A (en) 1977-01-01
SU1060118A3 (ru) 1983-12-07
CH614718A5 (en) 1979-12-14
NO144850B (no) 1981-08-17
NO764191L (no) 1977-06-13

Similar Documents

Publication Publication Date Title
DE2655500A1 (de) Glucosaminderivate und ein verfahren zu deren herstellung
EP0025495B1 (de) Lipophile Muramylpeptide, Verfahren zu deren Herstellung und deren Verwendung
DE2728324C2 (no)
EP0027258B1 (de) Phosphorylmuramylpeptide, Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln
EP0206037B1 (de) N-(2-Aminoacylamido-2-desoxy-hexosyl)-amide, -carbamate und -harnstoffe, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE3856279T2 (de) 7-Thia-Guanosin-Derivate mit antiviraler, antitumoraler, antimetastatischer und immunstimulierender Wirkung
EP0114787A2 (de) Neue Peptidderivate
EP0003833B2 (de) Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
US4310514A (en) Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
DE3586649T2 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
EP0000126B1 (de) Glucofuranosid-6-yl-Nitrosoharnstoffderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE69031448T2 (de) Halbsynthetische Gangliosidanaloge
EP0098520B1 (de) L-Alanyl-D-isoglutaminyl-adamantylamid, Verfahren zu seiner Herstellung und pharmazeutische Mittel mit dieser Verbindung
DD145274A5 (de) Verfahren zur darstellung neuer verbindungen des muramylpeptidtyps
EP0003788B1 (de) Glucofuranosyl-nitrosoharnstoffderivate, Verfahren zu deren Herstellung und ihre pharmazeutischen Präparate
DE69033027T2 (de) Di-lysogangliosidderivate
EP0005682B1 (de) Silyl-glucosaminderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
AT373266B (de) Verfahren zur herstellung neuer glucosederivate
AT373265B (de) Verfahren zur herstellung neuer glucosederivate
CH613981A5 (en) Process for the preparation of glucosamine derivatives
EP0050703A2 (de) Neue Glucosederivate und Verfahren zu ihrer Herstellung
CH613982A5 (en) Process for the preparation of glucosamine derivatives
WO1995006653A1 (de) Glycosylamide von 6-amino-6-desoxy-zuckern
DE4404370A1 (de) Glycosylamide von 6-Amino-6-desoxy-zuckern
DD142191A5 (de) Verfahren zur herstellung von n tief 1-glucofuranosid-6-yl-n tief 3-nitrosoharnstoffen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: REDIES, B., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 40

Q176 The application caused the suspense of an application

Ref document number: 2718010

Country of ref document: DE

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee